Lista de obras - Matthias Riemenschneider

A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.

artículo científico publicado en 2006

A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD.

artículo científico publicado en 2002

A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele

artículo científico publicado en 2002

A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease

artículo científico publicado en 2018

Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.

artículo científico publicado en 2006

Amyloid-β Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients

artículo científico publicado en 2015

Analysis of shared heritability in common disorders of the brain

artículo científico publicado en 2018

Apolipoprotein E polymorphism in German patients with frontotemporal degeneration

artículo científico publicado en 2002

Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease

artículo científico publicado en 2004

Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease.

artículo científico publicado en 2002

Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia.

artículo científico publicado en 2007

Association study between the D10S1423 microsatellite marker and Alzheimer's disease.

artículo científico publicado en 2005

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

scientific article published on 01 September 2019

Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid

artículo científico publicado en 2009

Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease.

artículo científico publicado en 2009

Cerebral glucose metabolism in patients with AD and different APOE genotypes

artículo científico publicado en 2005

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

artículo científico publicado en 2003

Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study

artículo científico

Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline

artículo científico publicado en 2000

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

artículo científico publicado en 2002

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

artículo científico publicado en 1996

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

artículo científico publicado en 2011

Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study.

artículo científico publicado en 2006

Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase

scientific article published on 01 September 1997

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

artículo científico publicado en 2009

Erratum: Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

article

Examination of the current top candidate genes for AD in a genome-wide association study

artículo científico publicado en 2009

Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease

artículo científico publicado en 2006

From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry

artículo científico publicado en 2011

Frontotemporal dementia and its subtypes: a genome-wide association study

artículo científico publicado en 2014

Frontotemporal lobar degeneration

artículo científico publicado en 2009

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

artículo científico publicado en 2014

Genetic analysis of MAPT haplotype diversity in frontotemporal dementia

artículo científico publicado en 2007

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

artículo científico publicado en 2019

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers

artículo científico publicado en 2017

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

artículo científico publicado en 2012

Haplotype structure, adaptive history and associations with exploratory behaviour of the DRD4 gene region in four great tit (Parus major) populations

artículo científico publicado en 2013

High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide

artículo científico publicado en 2016

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

artículo científico publicado en 1999

Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease.

artículo científico publicado en 2011

Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease

artículo científico publicado en 2003

Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease ⬇️

artículo científico publicado el 15 de mayo de 2003

Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease.

artículo científico publicado en 2009

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

artículo científico publicado en 2013

Meta-analysis of the association between variants in SORL1 and Alzheimer disease

artículo científico publicado en 2011

Mild cognitive disorder. Questions of definition, diagnosis, prognosis and therapy

artículo científico publicado en 2004

New Alzheimer amyloid beta responsive genes identified in human neuroblastoma cells by hierarchical clustering

artículo científico publicado en 2009

No association of TDP-43 with sporadic frontotemporal dementia

artículo científico publicado en 2007

No association of Tachykinin receptor 2 (TACR2) polymorphisms with Alzheimer's disease

artículo científico publicado en 2009

No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia

artículo científico publicado en 2006

No association of common VCP variants with sporadic frontotemporal dementia

artículo científico publicado en 2007

No association of lipase C polymorphisms with Alzheimer's disease

artículo científico publicado en 2009

No association of vacuolar protein sorting 26 polymorphisms with Alzheimer's disease

artículo científico publicado en 2006

Pharmacogenetics in psychiatry: state of the art

artículo científico publicado en 2018

Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.

artículo científico publicado en 2013

Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias

artículo científico publicado en 2003

Plasmalogens inhibit APP processing by directly affecting γ-secretase activity in Alzheimer's disease.

artículo científico publicado en 2012

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

artículo científico publicado en 2005

Prevention of interferon-stimulated gene expression using microRNA-designed hairpins

artículo científico publicado en 2008

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings

artículo científico publicado en 2001

Prion protein codon 129 polymorphism and risk of Alzheimer disease.

artículo científico publicado en 2004

Rare ABCA7 variants in 2 German families with Alzheimer disease.

artículo científico publicado en 2018

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

artículo científico publicado en 2017

Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease

artículo científico publicado en 2020

Sex-specific genetic predictors of Alzheimer's disease biomarkers

artículo científico publicado en 2018

TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.

artículo científico publicado en 2005

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

artículo científico publicado en 2002

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.

artículo científico publicado en 1998

The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients

artículo científico publicado en 2013

The cathepsin D (224C/T) polymorphism confers an increased risk to develop Alzheimer's disease in men.

artículo científico publicado en 2010

The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.

artículo científico publicado en 2006

The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster

artículo científico publicado en 2016

The role of biological markers in the early and differential diagnosis of Alzheimer's disease.

artículo científico publicado en 2002

Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.

artículo científico publicado en 2013

Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures.

artículo científico publicado en 2006

[Forgetfulness and light cognitive impairment. What can the physician still tolerate?]

artículo científico publicado en 2001

[Frontotemporal lobar degeneration. Part 1: diagnosis and treatment]

artículo científico publicado en 2009

[Guideline-adherent inpatient psychiatric psychotherapeutic treatment of behavioral and psychological symptoms of dementia : Normative definition of personnel requirements].

artículo científico publicado en 2016

[Tau protein. A potential biological indicator for early detection of Alzheimer disease]

artículo científico publicado en 1998

Lista de obras de Matthias Riemenschneider

A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.

A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD.

A polymorphism of the brain-derived neurotrophic factor (BDNF) is associated with Alzheimer's disease in patients lacking the Apolipoprotein E epsilon4 allele

A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease

Alpha2-macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease.

Amyloid-β Protein Precursor Cleavage Products in Postmortem Ventricular Cerebrospinal Fluid of Alzheimer's Disease Patients

Analysis of shared heritability in common disorders of the brain

Apolipoprotein E polymorphism in German patients with frontotemporal degeneration

Association analysis of genes involved in cholesterol metabolism located within the linkage region on chromosome 10 and Alzheimer's disease

Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease.

Association of the tau haplotype H2 with age at onset and functional alterations of glucose utilization in frontotemporal dementia.

Association study between the D10S1423 microsatellite marker and Alzheimer's disease.

Author Correction: Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid

Brain metabolic correlates of cerebrospinal fluid beta-amyloid 42 and tau in Alzheimer's disease.

Cerebral glucose metabolism in patients with AD and different APOE genotypes

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study

Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline

Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.

Cerebrospinal protein tau is elevated in early Alzheimer's disease.

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease

Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study.

Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase

Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

Erratum: Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

Examination of the current top candidate genes for AD in a genome-wide association study

Fine mapping of the MAPT locus using quantitative trait analysis identifies possible causal variants in Alzheimer's disease

From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry

Frontotemporal dementia and its subtypes: a genome-wide association study

Frontotemporal lobar degeneration

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease

Genetic analysis of MAPT haplotype diversity in frontotemporal dementia

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers

Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease

Haplotype structure, adaptive history and associations with exploratory behaviour of the DRD4 gene region in four great tit (Parus major) populations

High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

Intracellular APP Domain Regulates Serine-Palmitoyl-CoA Transferase Expression and Is Affected in Alzheimer's Disease.

Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease

Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease ⬇️

Lack of evidence to support the association of polymorphisms within the alpha- and beta-secretase genes (ADAM10/BACE1) with Alzheimer's disease.

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

Meta-analysis of the association between variants in SORL1 and Alzheimer disease

Mild cognitive disorder. Questions of definition, diagnosis, prognosis and therapy

New Alzheimer amyloid beta responsive genes identified in human neuroblastoma cells by hierarchical clustering

No association of TDP-43 with sporadic frontotemporal dementia

No association of Tachykinin receptor 2 (TACR2) polymorphisms with Alzheimer's disease

No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia

No association of common VCP variants with sporadic frontotemporal dementia

No association of lipase C polymorphisms with Alzheimer's disease

No association of vacuolar protein sorting 26 polymorphisms with Alzheimer's disease

Pharmacogenetics in psychiatry: state of the art

Pharmacogenomics in Alzheimer's disease: a genome-wide association study of response to cholinesterase inhibitors.

Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias

Plasmalogens inhibit APP processing by directly affecting γ-secretase activity in Alzheimer's disease.

Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.

Prevention of interferon-stimulated gene expression using microRNA-designed hairpins

Primary degenerative mild cognitive impairment: study population, clinical, brain imaging and biochemical findings

Prion protein codon 129 polymorphism and risk of Alzheimer disease.

Rare ABCA7 variants in 2 German families with Alzheimer disease.

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease

Sex-specific genetic predictors of Alzheimer's disease biomarkers

TNF polymorphisms in Alzheimer disease and functional implications on CSF beta-amyloid levels.

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

Tau protein in cerebrospinal fluid is significantly increased at the earliest clinical stage of Alzheimer disease.

The "DGPPN-Cohort": A national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients

The cathepsin D (224C/T) polymorphism confers an increased risk to develop Alzheimer's disease in men.

The cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease.

The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster

The role of biological markers in the early and differential diagnosis of Alzheimer's disease.

Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.

Weak independent association signals between IDE polymorphisms, Alzheimer's disease and cognitive measures.

[Forgetfulness and light cognitive impairment. What can the physician still tolerate?]

[Frontotemporal lobar degeneration. Part 1: diagnosis and treatment]

[Guideline-adherent inpatient psychiatric psychotherapeutic treatment of behavioral and psychological symptoms of dementia : Normative definition of personnel requirements].

[Tau protein. A potential biological indicator for early detection of Alzheimer disease]